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Knowledge, attitudes and practices of Canadian pediatric
emergency physicians regarding short-term opioid use:
a descriptive, cross-sectional survey
Megan Fowler MD, Samina Ali MDCM, Serge Gouin MDCM, Amy L. Drendel DO MS,
Naveen Poonai MD MSc, Maryna Yaskina PhD, Mithra Sivakumar RN, Esther Jun MD,
Kathryn Dong MD MSc; for Pediatric Emergency Research Canada

Abstract
Background: In the midst of the current opioid crisis, physicians are caught between balancing children’s optimal pain management and the risks of
opioid therapy. This study describes pediatric emergency physicians’ practice patterns for prescribing, knowledge and attitudes regarding, and perceived barriers to and facilitators of short-term use of opioids.
Methods: We created a survey tool using published methodology guidelines and distributed it from October to December 2017 to all physicians in the
Pediatric Emergency Research Canada database using Dillman’s tailored design method for mixed-mode surveys. We performed bivariable binomial
logistic regressions to ascertain the effects of clinically significant variables (e.g., training, age, sex, degree of worry regarding severe adverse events)
on use of opioids as a first-line treatment for moderate pain in the emergency department, and prescription of opioids for moderate or severe pain for
at-home use in children.
Results: Of the 224 physicians in the database, 136 (60.7%) completed the survey (60/111 [54.1%] women; median age 44 yr). Of the 136, 74
(54.4%) had subspecialty training. Intranasally administered fentanyl was the most commonly selected opioid for first-line treatment of moderate
(47 respondents [34.6%]) and severe (82 [60.3%]) pain due to musculoskeletal injury. On a scale of 0 (not worried) to 100 (extremely worried), phys
icians’ median score for worry regarding physical dependence was 6.0 (25th percentile 0.0, 75th percentile 16.0), for worry regarding addiction 10.0
(25th percentile 2.0, 75th percentile 20.0) and for worry regarding diversion of opioids 24.5 (25th percentile 14.0, 75th percentile 52.0). On a scale of 0
(not at all) to 100 (extremely), the median score for influence of the opioid crisis on willingness to prescribe opioids was 22.0 (25th percentile 8.0, 75th
percentile 49.0). The top 3 reported barriers to prescribing opioids were parental reluctance (57 [41.9%]), lack of clear guidelines for pediatric opioid
use (35 [25.7%]) and concern about adverse effects (33 [24.3%]). Binomial logistic regression did not identify any statistically significant variables
affecting use of opioids in the emergency department or prescribed for use at home.
Interpretation: Emergency department physicians appeared minimally concerned about physical dependence, addiction risk and the current opioid crisis when prescribing opioids to children. Evidence-based development of guidelines and protocols for use of opioids in children may improve phys
icians’ ability to manage pain in children responsibly and adequately.

P

ain is one of the most common reasons for visits to the
emergency department and accounts for up to 80% of
visits in North America.1,2 However, inadequate analgesia for children remains a worldwide problem.3,4 The
World Health Organization and the American Academy of
Pediatrics have long recommended the addition of opioids
for pain in children that does not respond to acetaminophen
or nonsteroidal anti-inflammatory drugs or both.5,6 With the
current international opioid crisis and lack of clear national
guidelines in Canada, physicians are caught between providing effective pain management and the risks of opioid therapy7,8 This is especially relevant in the emergency department, which has been implicated in the current crisis.9,10
There are limited studies describing physicians’ knowledge, attitudes and barriers regarding prescribing opioids to
children. A study from Brazil on pain management in pediatE148
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ric inpatient wards showed that the most common barriers to
pain management included fear of adverse drug reactions, fear
of opioid dependence and tolerance, and lack of knowledge or
understanding.11 In comparison, Ontario primary care phys
icians reported that they were most concerned about adult
patients’ running out of opioid medications early, demanding
fit-in appointments, losing prescriptions and developing opioid addiction.12
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The objectives of the present study were to describe pediatric emergency medicine physicians’ patterns of prescribing
short-term opioids in hypothetical scenarios of varying musculoskeletal injury pain in the emergency department and at
discharge; their perceived knowledge and attitudes regarding
prescribing short-term opioids, and their perceived barriers to
and facilitators of prescribing short-term opioids; and to relate
these findings to the physicians’ demographic characteristics.

Methods
Design, setting and participants

This was a descriptive, cross-sectional survey of pediatric
emergency physicians across Canada. Pediatric Emergency
Research Canada is a network of health care providers interested in pediatric emergency medicine, with representation
from all pediatric hospitals across the country. The 2017
Pediatric Emergency Research Canada physician database
constituted our study population. This study was conducted at
the Department of Pediatrics, University of Alberta between
October and December 2017.

Survey tool

Four members of the research team (M.F., S.A., S.G. and
E.J.) developed a survey tool following published guidelines
for self-administered clinician surveys.13 An expert panel (representing pediatric emergency medicine, pain management,
toxicology, addiction medicine and survey methodology)
informed tool development. After item generation, item
reduction and pretesting, the survey was pilot tested and
reviewed for sensibility by 5 pediatric emergency physicians
to ensure readability, and face and content validity
(Appendix 1, available at www.cmajopen.ca/content/8/1/
E148/suppl/DC1).
The survey was available in English and French. The
English-language survey was translated into French and then
back-translated into English to ensure validity by the Pediatric Emergency Research Program at the Centre hospitalier
universitaire Sainte-Justine, Montréal. The survey included
30 questions regarding physicians’ demographic characteristics, knowledge and attitudes regarding potential risks and safe
practice with opioid use (e.g., physical dependence, addiction),
current practice, and perceived barriers to and facilitators of
prescribing opioids (Appendix 2, available at www.cmajopen.
ca/content/8/1/E148/suppl/DC1). Physicians were presented
with 3 hypothetical musculoskeletal injury case scenarios to
determine analgesic preference in the emergency department
and at discharge. The cases represented mild (3/10), moderate
(6/10) or severe (9/10) pain, as defined by the World Health
Organization’s pain ladder.5 Participants were asked which
medication(s) (in combination or as monotherapy) they would
typically use for first- and second-line pain management in
the emergency department, as well as recommendations for
at-home pain management. They were also asked to select up
to 3 opioids that they frequently prescribed or used for moderate to severe pain in children aged 6–23 months, 2–5 years,
6–12 years and 13–18 years.

Survey implementation

Participants were contacted from October to December 2017.
We used Dillman’s tailored design method for mixed-mode
surveys to distribute the surveys.14 A prenotification email was
sent on day 0, followed by the electronic survey link on days 7
and 21. Consent was implied in completion of the survey.
Based on pilot work, the time to complete the survey was
10–15 minutes. All email addresses were confirmed as active
and current with Pediatric Emergency Research Canada.
Nonresponders to the electronic survey were mailed a
paper survey on day 35. Study data were collected and managed with the use of the REDCap electronic data capture tool
hosted by the Women and Children’s Health Research Institute, Edmonton.15 Response validity and data checks were built
into the REDCap database to avoid data entry errors, and participants were permitted to review and change their answers.
An arms-length research coordinator (M.S.) was responsible for distributing the survey, tracking participants’ response
status, mailing paper surveys, data entry and secure storage.
The study team was blinded to the identity of the respondents
and nonrespondents.
After completion of the survey, participants were offered a
$5 coffee gift card.

Statistical analysis

We summarized categorical data (e.g., sex, institution) with
frequency distributions and reported continuous data
(e.g., age, scales of worry and knowledge) using univariable
summaries (means, medians, standard deviations, ranges). We
performed bivariable binomial logistic regressions to ascertain
the effects of clinically important variables (e.g., training, age,
sex, degree of worry regarding severe adverse events) on use
of opioids as a first-line treatment of moderate pain in the
emergency department and prescription of opioids for moderate or severe pain for at-home use. A p value of < 0.05 was
considered statistically significant. We performed all statistical
analyses using SAS Version 9.4 (SAS Institute).

Ethics approval

This study received ethics approval from the University of
Alberta’s Health Research Ethics Board.

Results
At the time of study, the Pediatric Emergency Research Canada physician database included 224 physicians, including residents. Of the 224, 136 (60.7%) completed the survey
(113 electronically, 23 on paper). Respondents’ demographic
characteristics were representative of the Pediatric Emergency
Research Canada physician database (Table 1). Participants
were permitted to skip questions, and, therefore, response
rates varied by question.

Practice patterns for prescribing opioids and other
analgesic agents
Physicians’ practice patterns for prescribing opioids for moderate to severe pain in the emergency department and at
CMAJ OPEN, 8(1)
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Table 1: Respondents’ demographic characteristics*
No. (%) of
respondents†

Characteristic
Female sex (n = 111)

60 (54.0)

Age, yr, median (Q1, Q3) (n = 105)

44 (37, 49)

Province of practice (n = 111)
British Columbia

10 (9.0)

Alberta

23 (20.7)

Saskatchewan

2 (1.8)

Manitoba

4 (3.6)

Ontario

33 (29.7)

Quebec

27 (24.3)

Nova Scotia

7 (6.3)

Newfoundland and Labrador

5 (4.5)

Training background (n = 117)
Pediatric Emergency Fellowship

74 (63.2)

FRCP/CCFP-EM Emergency Medicine

19 (16.2)

General pediatrics training

18 (15.4)

Currently in fellowship/training

4 (3.4)

Other (Family Medicine, Pediatric Critical
Care)

2 (1.7)

Years in clinical practice, median (Q1, Q3)
(n = 109)

discharge are presented in Table 2. The most commonly
selected analgesics for use in the emergency department and
for home management are presented in Figure 1. Ibuprofen
was the most commonly selected analgesic for first-line
emergency department management and home management
for all 3 categories of pain. Intranasally administered fentanyl
was the most commonly selected opioid for first-line treatment of moderate (47 respondents [34.6%]) and severe
(82 [60.3%]) pain due to musculoskeletal injury in the emergency department.
Figure 2 depicts preferred opioids used in the emergency
department and recommended at discharge, based on age.
Morphine and fentanyl were the most commonly selected
opioids in the emergency department, across all age groups; in
the at-home setting, the most commonly selected opioid was
morphine for oral use, followed by oxycodone and hydromorphone. Notably, over one-third of respondents (49 [36.0%])
indicated that they would not prescribe opioids to be used at
home to children less than 2 years of age.

Knowledge regarding safe opioid use

19 (5, 19)

% pediatric patients, median (Q1, Q3)
(n = 110)

100 (100, 100)

Personal history of medical opioid use
(n = 110)

54 (49.1)

Family history of medical opioid use (n = 110)

65 (59.1)

Note: CCFP-EM = Canadian College of Family Physicians: Emergency Medicine,
FRCP = Fellow of the Royal College of Physicians, Q1 = 25th percentile, Q3 =
75th percentile.
*Respondents were allowed to skip questions, and, therefore, response rates
vary.
†Except where noted otherwise.

On a 100-point scale where 0 = extremely bad and 100 =
extremely good, physicians’ median score for self-reported
knowledge regarding safe opioid use was 73.0 (25th percentile
57.0, 75th percentile 85.0) in the emergency department and
66.5 (25th percentile 48.0, 75th percentile 78.0) for discharge
recommendations.
Of the 127 respondents who answered the question concerning the best mode to deliver education for clinicians
regarding safe opioid use in children, 49 (38.6%) selected Webbased independent study, 29 (22.8%) selected specific training
session or course, 18 (14.2%) selected conference or medical
event, and 17 (13.4%) selected video education sessions.
Sixty-two (48.1%) of 129 respondents reported having an
opioid-specific protocol or policy in their emergency department, and 14/129 (10.8%) reported having a protocol for discharge advice. Ninety-one (74.0%) of 123 physicians reported
that having an opioid protocol in their emergency department
would be helpful, specifically for morphine, fentanyl and
hydromorphone.

Table 2: Reported opioid use for moderate and severe musculoskeletal injury pain scenarios
No. (% [95% CI]) of respondents
n = 136
Moderate pain scenario

Severe pain scenario

Difference
between
moderate and
severe, %

Opioids as first-line treatment in
emergency department

62 (45.6 [37.2–54.0])

127 (93.4 [89.2–97.6])

47.8

Opioids as second-line treatment in
emergency department

118 (86.8 [81.1–92.5])

128 (94.1 [90.2–98.1])

7.4

Opioids for at-home use

29 (21.3 [14.4–28.2])

73 (53.7 [45.3–62.1])

32.4

122 (89.7 [84.6–94.8])

132 (97.1 [94.2–99.9])

7.4

Scenario

Total opioid use for emergency
department or at-home use or both
Note: CI = confidence interval.
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Figure 1: Physician-reported first-line pain medications in the emergency department (A), second-line pain medications in the emergency
department (B) and pain medications at discharge (C) for mild (3/10), moderate (6/10) and severe (9/10) pain scenarios. n = 136 for all questions.
Note: IM = intramuscular, IN = intranasal, IV = intravenous, PO = per os (oral).

Physicians reported wanting more knowledge regarding
the efficacy of various opioids (6/25 [24%]), opioid dosing,
indications, contraindications and duration of treatment (6/25
[24%]), risk of opioid dependence, addiction and diversion
(4/25 [16%]), and opioid adverse effects (3/25 [12%]).

Attitudes regarding adverse effects

On a 100-point scale where 0 = not worried and 100 =
extremely worried, physicians’ median score for worry
regarding development of physical dependence in children
was 6.0 (25th percentile 0.0, 75th percentile 16.0), for worry
regarding development of an opioid use disorder or addiction
in children 10.0 (25th percentile 2.0, 75th percentile 20.0)
and for worry regarding diversion of opioid prescriptions to

others 24.5 (25th percentile 14.0, 75th percentile 52.0). Phys
ician’s median scores for worry about severe adverse reactions at therapeutic dosages were as follows: apnea 16.5 (25th
percentile 8.0, 75th percentile 28.5) in the emergency department, 14.0 (25th percentile 4.0, 75th percentile 30.0) at
home; hypotension 16.0 (25th percentile 7.0, 75th percentile
28.0) in the emergency department, 9.0 (25th percentile 2.0,
75th percentile 19.0) at home; and cardiac arrest 4.0 (25th
percentile 0.0, 75th percentile 9.0) in the emergency department, 4.0 (25th percentile 0.0, 75th percentile 12.0) at home.
On a 100-point scale where 0 = not at all and 100 =
extremely, the median score for influence of adverse effects
(e.g., pruritis, nausea, vomiting, somnolence, constipation) on
respondents’ willingness to prescribe opioids to children was
CMAJ OPEN, 8(1)

E151

OPEN
Research

A

B
90

90

30

e
re
sc
rib

D

o

no

tp

on

e

PO
H

yd

ro
co
d

ei
od
C

ad

ol

ne

PO

PO
e

H

yd

O

Tr
am

e
in
or
ph
M

M

on

0

PO

10

0

PO

20

10

PO

20

40

e

30

50

or
ph

40

60

on

50

70

ro
m

60

6−23 mo
2−5 yr
6−12 yr
13−18 yr

xy
co
d

70

80

% of respondents

6−23 mo
2−5 yr
6−12 yr
13−18 yr

or
ph
i
M ne
or
P
ph O
i
n
Fe
e
I
nt
an V
Fe yl
nt IN
a
Fe nyl
O nta IV
x
H
yd yco nyl
IM
ro
d
m on
or
e
H
yd ph PO
ro
o
m ne
or
p PO
Tr h o n
am e
ad IV
ol
C
o
H
yd de PO
ro ine
co
do PO
ne
PO

% of respondents

80

Opioid

Opioid

Figure 2: Most frequently reported opioids used in the emergency department (A) and at discharge (B) for moderate or severe pain, according
to patient age. n = 136 for both questions. Note: IM = intramuscular, IN = intranasal, IV = intravenous, PO = per os (oral).

39.5 (25th percentile 16.0, 75th percentile 61.5) and for influence of Canada’s opioid crisis on respondents’ willingness to
prescribe opioids to children 22.0 (25th percentile 8.0, 75th
percentile 49.0).
Table 3 presents physicians’ self-reported frequency of
counselling regarding safe opioid use. More than 80% of
respondents (105 [81.4%]) indicated that they often or always
counselled families about the risks and adverse effects of opioids. In contrast, close to two-thirds (83 [64.3%]) reported
rarely or never performing a risk assessment before prescribing
opioids, and less than 20% (21 [16.3%)] often or always counselled families about safe disposal of leftover medications.

Perceived barriers to and facilitators of prescribing
short-term opioids
Table 4 presents perceived barriers to and facilitators of opioid use in the emergency department. Of the 52 respondents

who answered the question regarding ways to remove barriers to responsible prescribing of opioids to children, 28
(54%) reported the need for more education for physicians,
nurses and caregivers, 8 (15%) stated a need for research on
safe opioid use in children, 7 (13%) indicated a need for opioid guidelines, and 4 (8%) mentioned the need for
protocols.

Additional analyses

Binomial logistic regression to ascertain the effects of respondent demographic characteristics; worry regarding severe
adverse reactions, opioid dependence, or opioid use disorders
or addiction; and whether the respondent had an opioid protocol in his or her emergency department on the selection of
opioids for first-line management of moderate pain in the
emergency department and prescription of opioids for moderate or severe pain for at-home use did not identify any

Table 3: Self-reported frequency of providing counselling regarding safe opioid use
Response; no. (%) of respondents
n = 129
Statement

E152

Often/always

Sometimes

Rarely/never

When deciding whether or not to prescribe opioids, I perform a
screening risk assessment (e.g., history of opioid use disorder)

18 (14.0)

28 (21.7)

83 (64.3)

When prescribing opioids, I counsel patients and parents about
potential risks and adverse effects of opioids

105 (81.4)

14 (10.8)

10 (7.8)

When prescribing opioids, I counsel patients and parents about
how to safely secure the medication away from the patient and
other family members

53 (41.1)

30 (23.3)

46 (35.7)

When prescribing opioids, I counsel patients and parents about
how to properly dispose of leftover medication

21 (16.3)

17 (13.2)

91 (70.5)

CMAJ OPEN, 8(1)
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Table 4: Perceived barriers to and facilitators of opioid use in
the emergency department

Barrier/facilitator

No. (%) of
respondents*
n = 136

Barriers
Parental reluctance

57 (41.9)

Lack of clear guidelines for opioid use in
children

35 (25.7)

Concern about adverse effects

33 (24.3)

Concern about serious adverse events

30 (22.1)

Regulation of prescribing opioids (e.g., triplicate
prescription needed)

29 (21.3)

Assessing pain in younger children is difficult

27 (19.8)

Lack of comfort with medication dosing

21 (15.4)

Policy regarding nursing/monitoring of patients
who receive opioids

21 (15.4)

Concern for opioid use disorders and addiction

18 (13.2)

Lack of adequate research to guide practice

17 (12.5)

Consultant preference

16 (11.8)

Concern for opioid dependence

13 (9.6)

Fear that opioids can mask symptoms and lead
to missed diagnoses

3 (2.2)

Other

5 (3.7)

Facilitators
Personal clinical experience with opioid use in
children

108 (79.4)

Opportunity to monitor patients in emergency
department

90 (66.2)

Parental approval and understanding of
benefits/adverse effects of opioids

60 (44.1)

Good research available on opioid use in
children

51 (37.5)

Documented pain scores

51 (37.5)

Opioid-specific protocols in institution/
emergency department

47 (34.6)

Patient known to be not opioid naive and has
used opioids safely in the past

35 (25.7)

Other

2 (1.5)

*Multiple responses were permitted.

statistically significant variables (Appendix 3, available at
www.cmajopen.ca/content/8/1/E148/suppl/DC1).

Interpretation
Our participants reported high ibuprofen use for management of pain in children. Opioids were most commonly
selected for second-line management of moderate and
severe pain in the emergency department. The physicians
in our study appeared to be minimally concerned about

opioid dependence, addiction risk and the opioid crisis
when prescribing opioids to children.
Intranasally administered fentanyl was the opioid most
commonly selected by emergency physicians for first-line
treatment of moderate and severe pain in children. The intranasal route has become a popular route of delivering medications, as they can be administered quickly and without intravenous insertion.16 It is interesting to note that the reported
intranasal fentanyl use was high (60% for first-line management of severe pain) given the lack of definitive evidence
regarding its efficacy. The authors of a 2014 Cochrane review
evaluating intranasal fentanyl therapy were unable to draw
any conclusions comparing its efficacy to parenteral morphine
therapy.16 Subsequent modest-sized trials of intranasal fentanyl therapy have shown it to be comparable to intranasal
ketamine therapy for suspected fractures.17,18 However, large
multicentre trials are urgently needed to determine the efficacy of intranasal fentanyl therapy definitively.
The selection of opioids for second-line management of
moderate and severe pain in the emergency department is
congruent with international recommendations.5,6 The high
ibuprofen use reported is in line with the current evidence on
safety and efficacy for managing acute pain from musculoskeletal injury in children.19
The risk of opioid addiction and misuse in children is not
clearly understood, and there is conflicting evidence from
recent studies.20,21 McCabe and colleagues21 found that legitimate use of prescription opioids in adolescence was not associated with the development of a substance use disorder; however, a history of nonmedical use of prescription opioids in
adolescence was associated with increased odds of substance
use disorder. Miech and colleagues20 reported that prescribing
opioids to adolescents was independently associated with a
33% increase in risk of future opioid misuse. Interestingly,
Miech and colleagues20 also reported no associated risk for
future opioid misuse among adolescents with reported use of
alcohol and illegal drugs. With the current lack of strong
guiding evidence regarding risk of future misuse after medical
use of opioids in childhood, it is difficult to conclude how
worried physicians “should” be about this risk.
Until recently, codeine was the most commonly prescribed
orally administered opioid for children.22 In 2013, Health
Canada advised no codeine use in children less than
12 years;23 this advisory challenged physicians to change their
practice patterns and search for an alternative opioid for oral
use. There have been 3 recent trials studying oral morphine
therapy for musculoskeletal injury.24–26 In 2 trials, the investigators compared oral morphine therapy to ibuprofen, alone
and in combination, and found no significant difference in
efficacy.24,25 In addition, all 3 trials showed significantly more
adverse effects in the morphine group than in the ibuprofen
group. In contrast, physicians in our study reported that orally
administered morphine was their preferred opioid for moderate and severe pain at discharge.
Physicians indicated they want more research, education and
opioid-specific protocols and guidelines for pain management
in children. After parental reluctance, lack of clear guidelines
CMAJ OPEN, 8(1)
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and concern for adverse effects were the top reported barriers
to prescribing opioids in the emergency department.
Over the past 10 years, there has been a 53% increase in
hospital admissions for opioid poisonings in Canada.27 Youth
aged 15–24 years have the fastest growing rates of hospital
admissions, and intentional poisonings were the most prevalent for this age group, accounting for 44% of these admissions.27 These numbers are alarming, and, in response to the
opioid crisis, the Government of Canada developed a Joint
Statement of Action to Address the Opioid Crisis.28,29 In the
United States, the Centers for Disease Control and Prevention produced the 2016 Guidelines for Prescribing Opioids
for Chronic Pain.30 These documents fail to address the pediatric population, and there is worry that they are being extrapolated inappropriately to children.31 The current World
Health Organization guidelines target persisting or chronic
pain rather than acute pain,5 and the American Academy of
Pediatrics guideline, although still helpful, predates the opioid
crisis and does not provide direct guidance regarding choice
of medications, dosing or length of therapy.6
Health care leaders and policy-makers must examine the
current evidence and, with the help of experts in pediatric pain
management, develop national guidelines in Canada regarding
the indication for opioids, recommended dosing, duration of
treatment and safety concerns for opioid use in children.31
Until then, Canadian physicians are left without clear guidance
on how to prescribe opioids to children responsibly and adequately. Rigorous trials examining the effectiveness and safety
of opioids in children are lacking, however.
Few physicians reported performing a screening risk
assessment before prescribing opioids or counselling families
about how to dispose of leftover medication properly. Clin
icians need a quick, reliable, validated screening tool for identifying children at higher risk for complications related to opioid use in the emergency department. Furthermore, knowing
that most people with nonmedical use of prescription opioids
obtain opioids from family members or friends,32,33 physicians
must counsel patients about proper disposal of unused
medications.
Future robust studies examining the risk of opioid use disorder in children receiving short-term opioids may help
guide clinical decision-making. Qualitative studies examining
physicians’ decision-making steps would help us understand
physicians’ barriers to and facilitators of prescribing opioids
to children.

Limitations

Our study has several limitations. We had a modest response
rate of 60.7%; a higher response rate may have led to more
generalizable results. We created a survey tool, which has not
been validated. As with any survey study, the answers provided may have been influenced by respondent and recall bias.
The Pediatric Emergency Research Canada database includes
physicians who practise primarily at pediatric tertiary care
centres; therefore, our results may not be generalizable to
community physicians. Since we used hypothetical scenarios,
our results cannot be generalized automatically to real-life
E154
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scenarios. Finally, our scenarios did not explicitly provide
information regarding mental health status or personal or
family history of opioid use disorder or addiction, which may
have influenced physicians’ decisions in choosing opioids for
pain management.

Conclusion

Intranasally administered fentanyl was the most commonly
selected opioid for first-line management of moderate and
severe pain in children in the emergency department, and opioids were most commonly selected for second-line management of moderate and severe pain. Physicians appear to be
minimally concerned regarding opioid dependence, addiction
risk and the current opioid crisis when prescribing opioids to
children. There is an urgent need for robust evaluation of opioid dependence and addiction risk in children receiving opioids to inform physicians’ patient-counselling practices.
Development of opioid-specific guidelines and protocols
would likely improve physicians’ ability to manage pain for
children responsibly and adequately.
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